Tesamorelin dosage chart
This summary table compares available dose amounts and schedules by administration route.
| Route | Dose | Frequency & duration |
|---|---|---|
| Injectable | 1.4 mg (EGRIFTA SV) | Once daily |
| Injectable | 1.28 mg (EGRIFTA WR) | Once daily |
Tesamorelin dosage by administration route
Tesamorelin injectable dosage
EGRIFTA SV is 1.4 mg subcutaneously once daily; EGRIFTA WR is 1.28 mg subcutaneously once daily. The two formulations are not interchangeable. An alternative schedule uses reported daily subcutaneous amounts of 1–2 mg over 3–6 months. These generic amounts do not replace the formulation-specific 1.4 mg EGRIFTA SV or 1.28 mg EGRIFTA WR doses; the different presentations are not interchangeable by nominal milligrams.[1][2][8]
Tesamorelin stimulates GH release and raises IGF-1. Its labeled indication concerns excess abdominal fat in adults with HIV-associated lipodystrophy.[1][2][3]
Frequency and timing
Evening is the usual timing.[4]
Cycle length and breaks
A standard course length for Tesamorelin has not been established. A standard break interval between courses is not established.
Tesamorelin dosage calculator
Convert your chosen Tesamorelin amount into volume and U-100 syringe units. Adjust the inputs to match your vial and preparation.
Tesamorelin safety and side effects
Approval and product quality
FDA-approved injectable tesamorelin products exist for reducing excess abdominal fat in adults with HIV-associated lipodystrophy. The label does not cover general weight loss, fitness, or anti-aging use.[5][1][2][6]
Side effects and long-term safety
Injection-site and musculoskeletal symptoms are relevant tolerability concerns. Glucose intolerance or diabetes monitoring and IGF-1 elevation require attention. Long-term cardiovascular safety has not been established in labeling.[1][2]
Route-specific dosing limits
Key cautions involve active malignancy, pituitary-axis conditions, glucose changes, and other contexts where GH/IGF-1 signaling can be inappropriate. Additional schedules attributed to Everything Peptide are reported patterns; citing research does not make these schedules clinically established or approved product instructions.[1][8]
Common Tesamorelin dosage questions
How do EGRIFTA SV and EGRIFTA WR doses differ?
When is Tesamorelin administered?
Evening is the usual timing.[4]
Does Tesamorelin have a standard cycle or break interval?
A standard course length for Tesamorelin has not been established. A standard break interval between courses is not established.
